Cefdinir Powder, For Suspension
Product Images NDC 50090-6417

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 50090-6417). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cefdinir Str)

Chemical structure of cefdinir, showing its molecular framework with labeled atoms and bonds, characteristic of this antibacterial agent used in oral suspension form.*

FDA Label Image

Label Image (Lbl500906417)

Cefdinir 125 mg/5 mL powder for oral suspension label from A-S Medication Solutions. The label includes NDC 50090-6417-0 and states that each 5 mL of reconstituted suspension contains 125 mg of cefdinir. It specifies storage instructions to keep the dry powder at 68 to 77 degrees Fahrenheit. The reconstituted volume is 60 mL. The label also notes to see the package insert for dosing information and indicates the product is distributed by A-S Medication Solutions in Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.